4.5 Article

Plasma Neurofilament Light and Longitudinal Progression of White Matter Hyperintensity in Elderly Persons Without Dementia

Journal

JOURNAL OF ALZHEIMERS DISEASE
Volume 75, Issue 3, Pages 729-737

Publisher

IOS PRESS
DOI: 10.3233/JAD-200022

Keywords

Alzheimer's disease neuroimaging initiative; cognitively decline; non-dementia elders; noninvasive biomarker; plasma neurofilament light protein; white matter hyperintensity

Categories

Funding

  1. National Natural Science Foundation of China [91849126]
  2. National Key R&D Program of China [2018YFC1314700]
  3. Shanghai Municipal Science and Technology Major Project [2018SHZDZX01]
  4. ZHANGJIANG LAB, Tianqiao, Fudan Universit
  5. Chrissy Chen Institute, Fudan University
  6. Frontiers Center for Brain Science of Ministry of Education, Fudan University
  7. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  8. DOD ADNI (Department of Defense award) [W81XWH-12-2-0012]
  9. National Institute on Aging
  10. National Institute of Biomedical Imaging and Bioengineering
  11. AbbVie
  12. Alzheimer's Association
  13. Alzheimer's Drug Discovery Foundation
  14. Araclon Biotech
  15. BioClinica, Inc.
  16. Biogen
  17. Bristol-Myers Squibb Company
  18. CereSpir, Inc.
  19. Cogstate
  20. Eisai Inc.
  21. Elan Pharmaceuticals, Inc.
  22. Eli Lilly and Company
  23. EuroImmun
  24. F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.
  25. Fujirebio
  26. GE Healthcare
  27. IXICO Ltd.
  28. Janssen Alzheimer Immunotherapy Research & Development, LLC.
  29. Johnson & Johnson Pharmaceutical Research & Development LLC.
  30. Lumosity
  31. Lundbeck
  32. Merck Co., Inc.
  33. Meso Scale Diagnostics, LLC.
  34. NeuroRx Research
  35. Neurotrack Technologies
  36. Novartis Pharmaceuticals Corporation
  37. Pfizer Inc.
  38. Piramal Imaging
  39. Servier
  40. Takeda Pharmaceutical Company
  41. Transition Therapeutics
  42. Canadian Institutes of Health Research
  43. State Key Laboratory of Neurobiology of Ministry of Education, Fudan University

Ask authors/readers for more resources

White matter hyperintensities (WMH) is mainly caused by cerebrovascular injury and may also increase the possibilities of progression to Alzheimer's disease. The present study aims to determine whether plasma neurofilament light (NFL) protein levels could predict the progression of WMH volume in elderly persons without dementia. The present study enrolled 1029 non-dementia participants from the Alzheimer's Disease Neuroimaging Initiative in which all had measurements of plasma NFL and WMH at baseline and 589 had longitudinal measurements during follow-up. Spearman correlation analyses and regression models were used to assess cross-sectional and longitudinal associations between plasma NFL and WMH. Plasma NFL concentration had a moderately strong correlation with WMH at baseline (r = 0.17, p < 0.001). Longitudinal analyses showed that higher baseline plasma NFL concentration was associated with accelerated progression of WMH (beta=0.015, p = 0.007). Furthermore, higher change rates of plasma NFL could predict faster progression of WMH in the future (beta=0.581, p = 0.002). The results of the study suggest that plasma NFL level might be used as a noninvasive biomarker to track variation trend in WMH in elderly persons without dementia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available